Your browser doesn't support javascript.
loading
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions.
Repetto, Matteo; Crimini, Edoardo; Giugliano, Federica; Morganti, Stefania; Belli, Carmen; Curigliano, Giuseppe.
Afiliação
  • Repetto M; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
  • Crimini E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Giugliano F; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
  • Morganti S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Belli C; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
  • Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Expert Rev Clin Pharmacol ; 14(10): 1233-1252, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34591728
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Fatores de Crescimento de Fibroblastos / Fatores de Crescimento de Fibroblastos / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Fatores de Crescimento de Fibroblastos / Fatores de Crescimento de Fibroblastos / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália